Skip to content

Multicentre Randomized trial of Ghrelin in anterior circulation ischemic stroke treated with endovascular thrombectomy. A randomized phase 2 trial.

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-515705-26-00
Enrollment
80
Registered
2024-10-15
Start date
2024-11-11
Completion date
Unknown
Last updated
2025-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Brief summary

score on the NIHSS at seven days (±1) after stroke onset or at discharge, if earlier

Detailed description

the score on the mRS at 90 days (±14) after stroke onset, the score on Barthel index at 90 days (±14) after stroke onset, mortality at 90 days (±14), scores on the NIHSS at 24 (±6) and 72 (±12) hours after stroke onset, score on the telephone version of the Montreal Cognitive Assessment (t-MoCA) at 90 days (±14), infarct size at 72 hours (±24) (based on MRI measurements), blood glucose levels at days 1-7 (or until discharge), blood pressure at days 1-7 (or until discharge), body temperature at days 1-7 (or until discharge), SAEs

Interventions

DRUGAcyl-ghreline

Sponsors

Rijnstate Ziekenhuis Stichting
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
score on the NIHSS at seven days (±1) after stroke onset or at discharge, if earlier

Secondary

MeasureTime frame
the score on the mRS at 90 days (±14) after stroke onset, the score on Barthel index at 90 days (±14) after stroke onset, mortality at 90 days (±14), scores on the NIHSS at 24 (±6) and 72 (±12) hours after stroke onset, score on the telephone version of the Montreal Cognitive Assessment (t-MoCA) at 90 days (±14), infarct size at 72 hours (±24) (based on MRI measurements), blood glucose levels at days 1-7 (or until discharge), blood pressure at days 1-7 (or until discharge), body temperature at days 1-7 (or until discharge), SAEs

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026